Literature DB >> 15583006

Functional interaction of protein kinase Calpha with the tyrosine kinases Syk and Src in human platelets.

Giordano Pula1, David Crosby, Julie Baker, Alastair W Poole.   

Abstract

There is a high degree of cross-talk between tyrosine phosphorylation and the serine/threonine phosphorylation signaling pathways. Here we show a physical and functional interaction between the classical protein kinase C isoform (cPKC), PKCalpha, and two major nonreceptor tyrosine kinases in platelets, Syk and Src. In the presence of the cPKC-selective inhibitor Go6976, platelet 5-hydroxytryptamine release was abolished in response to co-activation of glycoproteins VI and Ib-IX-V by the snake venom alboaggregin A, whereas platelet aggregation was substantially inhibited. Of the two platelet cPKCs, PKCalpha but not PKCbeta was activated, occurring in an Syk- and phospholipase C-dependent manner. Syk and PKCalpha associate in a stimulation-dependent manner, requiring Syk but not PKC activity. PKCalpha and Syk also co-translocate from the cytosol to the plasma membrane upon platelet activation, in a manner dependent upon the activities of both kinases. Although PKCalpha is phosphorylated on tyrosine downstream of Syk, we provide evidence against phosphorylation of Syk by PKCalpha, consistent with a lack of effect of PKCalpha inhibition on Syk activity. PKCalpha also associates with Src; although in contrast to interaction with Syk, PKCalpha activity is required for the association of these kinases but not the stimulation-induced translocation of Src to the cell membrane. Finally, the activity of Src is negatively regulated by PKC, as shown by potentiation of Src activity in the presence of the PKC inhibitors GF109203X or Go6976. Therefore, there is a complex interplay between PKCalpha, Syk, and Src involving physical interaction, phosphorylation, translocation within the cell, and functional activity regulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15583006     DOI: 10.1074/jbc.M409212200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Therapeutic potential for protein kinase C inhibitor in vascular restenosis.

Authors:  Richard Qinxue Ding; Jerry Tsao; Hong Chai; Daria Mochly-Rosen; Wei Zhou
Journal:  J Cardiovasc Pharmacol Ther       Date:  2010-12-23       Impact factor: 2.457

2.  Molecular mechanism and functional implications of thrombin-mediated tyrosine phosphorylation of PKCdelta in platelets.

Authors:  Swaminathan Murugappan; Haripriya Shankar; Surya Bhamidipati; Robert T Dorsam; Jianguo Jin; Satya P Kunapuli
Journal:  Blood       Date:  2005-04-05       Impact factor: 22.113

3.  Gq pathway regulates proximal C-type lectin-like receptor-2 (CLEC-2) signaling in platelets.

Authors:  Rachit Badolia; Vaishali Inamdar; Bhanu Kanth Manne; Carol Dangelmaier; Johannes A Eble; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2017-07-13       Impact factor: 5.157

4.  Modulation of gastric mucosal inflammatory responses to Helicobacter pylori via ghrelin-induced protein kinase Cδ tyrosine phosphorylation.

Authors:  B L Slomiany; A Slomiany
Journal:  Inflammopharmacology       Date:  2014-05-20       Impact factor: 4.473

5.  In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs.

Authors:  Angela Cassese; Iolanda Esposito; Francesca Fiory; Alessia P M Barbagallo; Flora Paturzo; Paola Mirra; Luca Ulianich; Ferdinando Giacco; Claudia Iadicicco; Angela Lombardi; Francesco Oriente; Emmanuel Van Obberghen; Francesco Beguinot; Pietro Formisano; Claudia Miele
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

6.  Autocrine amplification of integrin αIIbβ3 activation and platelet adhesive responses by deoxyribose-1-phosphate.

Authors:  Dina S Vara; Michelangelo Campanella; Ilaria Canobbio; Warwick B Dunn; Giuseppe Pizzorno; Michio Hirano; Giordano Pula
Journal:  Thromb Haemost       Date:  2013-03-14       Impact factor: 5.249

7.  PKCalpha regulates platelet granule secretion and thrombus formation in mice.

Authors:  Olga Konopatskaya; Karen Gilio; Matthew T Harper; Yan Zhao; Judith M E M Cosemans; Zubair A Karim; Sidney W Whiteheart; Jeffery D Molkentin; Paul Verkade; Steve P Watson; Johan W M Heemskerk; Alastair W Poole
Journal:  J Clin Invest       Date:  2009-01-19       Impact factor: 14.808

8.  Functional divergence of platelet protein kinase C (PKC) isoforms in thrombus formation on collagen.

Authors:  Karen Gilio; Matthew T Harper; Judith M E M Cosemans; Olga Konopatskaya; Imke C A Munnix; Lenneke Prinzen; Michael Leitges; Qinghang Liu; Jeffery D Molkentin; Johan W M Heemskerk; Alastair W Poole
Journal:  J Biol Chem       Date:  2010-05-17       Impact factor: 5.157

9.  The novel NOX inhibitor 2-acetylphenothiazine impairs collagen-dependent thrombus formation in a GPVI-dependent manner.

Authors:  D Vara; M Campanella; G Pula
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

Review 10.  Protein kinase Calpha: disease regulator and therapeutic target.

Authors:  Olga Konopatskaya; Alastair W Poole
Journal:  Trends Pharmacol Sci       Date:  2009-12-05       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.